CN1527045A - 测定血液中葡萄糖的方法和检测条 - Google Patents
测定血液中葡萄糖的方法和检测条 Download PDFInfo
- Publication number
- CN1527045A CN1527045A CNA2004100330205A CN200410033020A CN1527045A CN 1527045 A CN1527045 A CN 1527045A CN A2004100330205 A CNA2004100330205 A CN A2004100330205A CN 200410033020 A CN200410033020 A CN 200410033020A CN 1527045 A CN1527045 A CN 1527045A
- Authority
- CN
- China
- Prior art keywords
- test strip
- sample
- glucose
- group
- detector bar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 60
- 239000008103 glucose Substances 0.000 title claims abstract description 60
- 210000004369 blood Anatomy 0.000 title claims abstract description 35
- 239000008280 blood Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 40
- 238000012360 testing method Methods 0.000 title claims description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 31
- 229920000642 polymer Polymers 0.000 claims abstract description 17
- 238000001514 detection method Methods 0.000 claims description 35
- 238000006243 chemical reaction Methods 0.000 claims description 31
- 239000012528 membrane Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 14
- 229920006393 polyether sulfone Polymers 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 230000001419 dependent effect Effects 0.000 claims description 9
- -1 tetrazole compounds Chemical class 0.000 claims description 9
- 210000003743 erythrocyte Anatomy 0.000 claims description 8
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 8
- 239000004695 Polyether sulfone Substances 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 239000004793 Polystyrene Substances 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- 108010015776 Glucose oxidase Proteins 0.000 claims description 3
- 239000004366 Glucose oxidase Substances 0.000 claims description 3
- 102000005548 Hexokinase Human genes 0.000 claims description 3
- 108700040460 Hexokinases Proteins 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229940116332 glucose oxidase Drugs 0.000 claims description 3
- 235000019420 glucose oxidase Nutrition 0.000 claims description 3
- LJXXBBCNKKOAHS-UHFFFAOYSA-N n-phenylphenoxazin-3-imine Chemical class C1=CC=CC=C1N=C1C=C2OC3=CC=CC=C3N=C2C=C1 LJXXBBCNKKOAHS-UHFFFAOYSA-N 0.000 claims description 3
- DLZPPUIHGWXDNJ-UHFFFAOYSA-N n-phenylphenothiazin-3-imine Chemical class C1=CC=CC=C1N=C1C=C2SC3=CC=CC=C3N=C2C=C1 DLZPPUIHGWXDNJ-UHFFFAOYSA-N 0.000 claims 2
- 230000001590 oxidative effect Effects 0.000 claims 2
- 238000005534 hematocrit Methods 0.000 abstract description 10
- 239000000523 sample Substances 0.000 description 72
- 239000000203 mixture Substances 0.000 description 22
- 238000002310 reflectometry Methods 0.000 description 18
- 230000003287 optical effect Effects 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 231100000673 dose–response relationship Toxicity 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- VFXZKNGPBLVKPC-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;sodium Chemical compound [Na].OCCN1CCN(CCS(O)(=O)=O)CC1 VFXZKNGPBLVKPC-UHFFFAOYSA-N 0.000 description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- BWUHFIMIYXLIIO-UHFFFAOYSA-N 5-(phenothiazin-3-ylideneamino)benzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC(C(=O)O)=CC(N=C2C=C3SC4=CC=CC=C4N=C3C=C2)=C1 BWUHFIMIYXLIIO-UHFFFAOYSA-N 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- 101001102158 Homo sapiens Phosphatidylserine synthase 1 Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000005041 Mylar™ Substances 0.000 description 2
- 102100039298 Phosphatidylserine synthase 1 Human genes 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101710138959 NAD-specific glutamate dehydrogenase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004447 accommodation reflex Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 102000020006 aldose 1-epimerase Human genes 0.000 description 1
- 108091022872 aldose 1-epimerase Proteins 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002832 nitroso derivatives Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003447 supported reagent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44441403P | 2003-02-04 | 2003-02-04 | |
| US60/444414 | 2003-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1527045A true CN1527045A (zh) | 2004-09-08 |
Family
ID=32655746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2004100330205A Pending CN1527045A (zh) | 2003-02-04 | 2004-02-03 | 测定血液中葡萄糖的方法和检测条 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7439033B2 (https=) |
| EP (1) | EP1445329A3 (https=) |
| JP (1) | JP4417738B2 (https=) |
| CN (1) | CN1527045A (https=) |
| AU (1) | AU2004200386A1 (https=) |
| CA (1) | CA2455669A1 (https=) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102253085A (zh) * | 2011-03-11 | 2011-11-23 | 桂林优利特医疗电子有限公司 | 校正条、含校正代码的检测条及检测装置 |
| CN103088108A (zh) * | 2012-11-16 | 2013-05-08 | 李立和 | 葡萄糖脱氢酶法检测葡萄糖的试剂盒及制备方法 |
| CN104160277A (zh) * | 2012-01-11 | 2014-11-19 | 嘉泉大学校产学协力团 | 用于测量血糖水平的单元、包含该单元的系统以及用于测量血糖水平的方法 |
| CN108120794A (zh) * | 2017-12-21 | 2018-06-05 | 深圳市赛亿科技开发有限公司 | 一种智能杯子及其检测饮料中葡萄糖浓度的方法 |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2455669A1 (en) | 2003-02-04 | 2004-08-04 | Bayer Healthcare, Llc | Method and test strip for determining glucose in blood |
| US7964372B2 (en) * | 2004-12-13 | 2011-06-21 | Bayer Healthcare Llc | Size self-limiting compositions and test devices for measuring analytes in biological fluids |
| US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
| US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
| EP1928316B1 (en) | 2005-09-30 | 2014-02-26 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
| WO2008043041A1 (en) | 2006-10-04 | 2008-04-10 | University Of Washington | Method and device for rapid parallel microfluidic molecular affinity assays |
| WO2009076268A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator |
| WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
| EP2299904B1 (en) | 2008-06-06 | 2019-09-11 | Intuity Medical, Inc. | Medical measurement method |
| JP5642066B2 (ja) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | 体液の試料内に含まれている検体の存在または濃度を決定する検定を行う方法および装置 |
| US20110151479A1 (en) * | 2008-08-25 | 2011-06-23 | University Of Washington | Microfluidic systems incorporating flow-through membranes |
| EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
| CA2843945C (en) | 2011-08-03 | 2022-06-21 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
| US20130047415A1 (en) * | 2011-08-26 | 2013-02-28 | Lifescan Scotland Ltd. | Use of chamber height to affect calibration code in test strip manufacturing |
| US20140273270A1 (en) * | 2013-03-14 | 2014-09-18 | Polymer Technology Systems, Inc. | Direct temperature measurement of a test strip |
| JP7066726B2 (ja) * | 2017-01-27 | 2022-05-13 | ベクトン・ディキンソン・アンド・カンパニー | 流体試料中のグルコース濃度を検出するための垂直流アッセイデバイス |
| KR102082898B1 (ko) * | 2018-04-18 | 2020-02-28 | 가천대학교 산학협력단 | 병원균 검출을 위한 비색 검출 장치 및 그의 제조방법 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631174A (en) * | 1978-05-02 | 1986-12-23 | Fuji Photo Film Co., Ltd. | Multilayer chemical analysis member having an outer waterproof layer |
| US4495291A (en) * | 1981-03-06 | 1985-01-22 | Graphic Controls Corporation | Indicators for ethylene oxide |
| JPS57200862A (en) * | 1981-06-05 | 1982-12-09 | Fuji Photo Film Co Ltd | Mutilayer analysis element utilizing unique binding reaction |
| JPS6329246A (ja) * | 1986-07-10 | 1988-02-06 | イ−ストマン コダツク カンパニ− | 展開調節域を有する分析要素 |
| US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5049487A (en) | 1986-08-13 | 1991-09-17 | Lifescan, Inc. | Automated initiation of timing of reflectance readings |
| US5049394A (en) | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
| JPH0721455B2 (ja) * | 1988-12-01 | 1995-03-08 | 株式会社京都第一科学 | 液体試料中の特定成分を分析するための用具および方法 |
| US5306623A (en) * | 1989-08-28 | 1994-04-26 | Lifescan, Inc. | Visual blood glucose concentration test strip |
| AU640162B2 (en) * | 1989-08-28 | 1993-08-19 | Lifescan, Inc. | Blood separation and analyte detection techniques |
| US5126275A (en) | 1990-09-19 | 1992-06-30 | Miles Inc. | Analytical method using tetrazolium salt indicators having a reflectance plateau |
| CA2049237C (en) | 1990-09-19 | 1999-10-19 | Gunther Beck | 2-thiazolyl tetrazolium salt indicators |
| RU2100719C1 (ru) * | 1991-06-25 | 1997-12-27 | Луциа Бауманн-Шилп | Способ высушивания шламов и устройство для его осуществления |
| US5260002A (en) * | 1991-12-23 | 1993-11-09 | Vanderbilt University | Method and apparatus for producing uniform polymeric spheres |
| DE4311464A1 (de) | 1993-04-08 | 1994-10-13 | Boehringer Mannheim Gmbh | Verfahren zur kolorimetrischen Bestimmung eines Analyten mit einer PQQ-abhängigen Dehydrogenase |
| CA2127172C (en) * | 1993-08-05 | 1998-07-14 | Amy H. Chu | Analyte detection device and process |
| US5360595A (en) * | 1993-08-19 | 1994-11-01 | Miles Inc. | Preparation of diagnostic test strips containing tetrazolium salt indicators |
| US5520786A (en) | 1995-06-06 | 1996-05-28 | Bayer Corporation | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof |
| AU722471B2 (en) | 1995-10-17 | 2000-08-03 | Lifescan, Inc. | Blood glucose strip having reduced sensitivity to hematocrit |
| JP3647000B2 (ja) * | 1995-10-27 | 2005-05-11 | アークレイ株式会社 | 液体試料分析用具及び分析方法 |
| IL120587A (en) | 1996-04-04 | 2000-10-31 | Lifescan Inc | Reagent test strip for determination of blood glucose |
| DE19629657A1 (de) * | 1996-07-23 | 1998-01-29 | Boehringer Mannheim Gmbh | Volumenunabhängiger diagnostischer Testträger und Verfahren zur Bestimmung von Analyt mit dessen Hilfe |
| DE19781288B4 (de) * | 1996-11-08 | 2005-09-29 | Amira Medical, Scotts Valley | Opake Reaktionsmatrix zur Analyse von Vollblut |
| US6040195A (en) * | 1997-06-10 | 2000-03-21 | Home Diagnostics, Inc. | Diagnostic sanitary test strip |
| US6284194B1 (en) * | 1998-03-11 | 2001-09-04 | Albert E. Chu | Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity |
| CN1116919C (zh) | 1998-04-07 | 2003-08-06 | 成都迪康血液科技有限公司 | 小面积中空纤维膜血浆分离滤器 |
| US6162397A (en) | 1998-08-13 | 2000-12-19 | Lifescan, Inc. | Visual blood glucose test strip |
| JP2000350588A (ja) * | 1999-04-08 | 2000-12-19 | Koji Hayade | グルコース脱水素酵素 |
| US6193873B1 (en) * | 1999-06-15 | 2001-02-27 | Lifescan, Inc. | Sample detection to initiate timing of an electrochemical assay |
| US6696240B1 (en) * | 1999-10-26 | 2004-02-24 | Micronix, Inc. | Capillary test strip to separate particulates |
| US6872299B2 (en) * | 2001-12-10 | 2005-03-29 | Lifescan, Inc. | Passive sample detection to initiate timing of an assay |
| WO2003056163A1 (en) * | 2001-12-21 | 2003-07-10 | Polymer Technology Systems, Inc. | Test strip and method for determining hdl cholesterol concentration from whole blood of plasma |
| CA2455669A1 (en) | 2003-02-04 | 2004-08-04 | Bayer Healthcare, Llc | Method and test strip for determining glucose in blood |
-
2004
- 2004-01-22 CA CA002455669A patent/CA2455669A1/en not_active Abandoned
- 2004-01-29 EP EP04001906A patent/EP1445329A3/en not_active Withdrawn
- 2004-01-29 US US10/767,963 patent/US7439033B2/en not_active Expired - Lifetime
- 2004-02-03 JP JP2004026598A patent/JP4417738B2/ja not_active Expired - Fee Related
- 2004-02-03 CN CNA2004100330205A patent/CN1527045A/zh active Pending
- 2004-02-03 AU AU2004200386A patent/AU2004200386A1/en not_active Abandoned
-
2008
- 2008-10-06 US US12/287,112 patent/US20090075389A1/en not_active Abandoned
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102253085A (zh) * | 2011-03-11 | 2011-11-23 | 桂林优利特医疗电子有限公司 | 校正条、含校正代码的检测条及检测装置 |
| CN104160277A (zh) * | 2012-01-11 | 2014-11-19 | 嘉泉大学校产学协力团 | 用于测量血糖水平的单元、包含该单元的系统以及用于测量血糖水平的方法 |
| CN103088108A (zh) * | 2012-11-16 | 2013-05-08 | 李立和 | 葡萄糖脱氢酶法检测葡萄糖的试剂盒及制备方法 |
| CN108120794A (zh) * | 2017-12-21 | 2018-06-05 | 深圳市赛亿科技开发有限公司 | 一种智能杯子及其检测饮料中葡萄糖浓度的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004200386A1 (en) | 2004-08-19 |
| JP2004239906A (ja) | 2004-08-26 |
| EP1445329A2 (en) | 2004-08-11 |
| EP1445329A3 (en) | 2005-12-28 |
| US20040185517A1 (en) | 2004-09-23 |
| US7439033B2 (en) | 2008-10-21 |
| JP4417738B2 (ja) | 2010-02-17 |
| US20090075389A1 (en) | 2009-03-19 |
| CA2455669A1 (en) | 2004-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1527045A (zh) | 测定血液中葡萄糖的方法和检测条 | |
| AU778966B2 (en) | Electrochemical test strip for use in analyte determination | |
| CA2590944C (en) | Size self-limiting compositions and test devices for measuring analytes in biological fluids | |
| CN1184480C (zh) | 用于测定血糖的试剂检验带 | |
| CA2457665C (en) | Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method | |
| US20040219624A1 (en) | Methods and devices for use in analyte concentration determination assays | |
| EP1532267A2 (en) | Test strip for detection of analyte and methods of use | |
| JP2004325449A (ja) | 左利きにも右利きにも使える毛細管充填試験片 | |
| AU2007231819B8 (en) | Electrochemical test strip for use in analyte determination | |
| HK1189038A (zh) | 用於测量生物液体中的分析物的自我限定大小的组合物和检验设备 | |
| JPH01107136A (ja) | 液体分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20040908 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |